Results 71 to 80 of about 50,358 (293)

Current Evidence for Circulating Tumor DNA in Sarcoma: Challenges and Opportunities for Clinical Application

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Sarcomas represent a diverse group of mesenchymal tumors with high rates of recurrence after resection. While recent technical advances have enabled the detection of rare circulating tumor DNA (ctDNA) in other malignancies, the complexity and heterogeneity of sarcoma genomics have historically limited ctDNA in these cancers.
Kristin E. Goodsell   +5 more
wiley   +1 more source

Primary Omental Myxoid Leiomyosarcoma: Report of a Case and a Review of the Literature [PDF]

open access: yes, 2009
A 41-year-old Japanese woman who presented with right lower abdominal pain underwent partial omental resection with tumor excision, leaving no residual tumor.
Sawai, Terumitsu   +10 more
core  

Intussusception Secondary to Metastatic Bladder Leiomyosarcoma: a Case Report and Review of the Literature [PDF]

open access: yes
Intussusception, where one intestinal segment telescopes into another, is rare in adults, representing 5% of all intussusception cases and 1% of bowel obstructions. This case details a 57-year-old man with primary bladder leiomyosarcoma metastatic to the
Muhammed Salih Süer   +2 more
core   +1 more source

Primary Breast Leiomyosarcoma [PDF]

open access: yes, 2013
Primary leiomyosarcoma of the breast is an extremely rare neoplasm. Only few cases have been reported in the literature. We report here a case of breast leiomyosarcoma in a 44-years-old female and we discuss the data of the existing ...
S. Arifi   +7 more
core   +1 more source

Current approaches in nanostructured biomaterials in treatment of leiomyosarcoma

open access: yesIntelligent Pharmacy
One form of uncommon cancer that develops in the smooth muscles is called leiomyosarcoma, or LMS. The body's hollow organs, such as the stomach, bladder, intestines, and blood vessels, contain smooth muscles.
Shraddha Vikas Jadhav   +4 more
doaj   +1 more source

Leiomyosarcoma of the pancreas [PDF]

open access: yesHPB, 2001
This is a single case report of a rare tumour, pancreatic leiomyosarcoma.A 44-year-old woman presented with a painless epigastric mass, and CT scan showed a cystic lesion of the head of pancreas. An associated epigastric mass was found to be a lipoma. Pancreatoduodenectomy was successfully performed.
Deveaux, P.G., Aranha, G.V., Yong, S.
openaire   +2 more sources

Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study

open access: yesBMC Cancer, 2019
The clinical impact of adjuvant radiotherapy on uterine sarcoma is unclear, and may depend on the histological type. Hence, the aim of this study was to evaluate clinical outcomes of adjuvant radiotherapy after total hysterectomy in patients with ...
Yuan Li, H. Ren, Junmei Wang
semanticscholar   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma

open access: yesCancer Science, 2018
Uterine leiomyosarcoma (u‐LMS) and endometrial stromal sarcoma (ESS) are among the most frequent soft tissue sarcomas, which, in adults, lead to fatal lung metastases and patients have an extremely poor prognosis.
H. Tsuyoshi, Y. Yoshida
semanticscholar   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy